Auvelity (Dextromethorphan / Bupropion)

Auvelity is a medicine used to treat depression in adults and agitation in people with Alzheimer's dementia. It's taken as a pill. It combines two medicines that work together to change how certain brain chemicals send signals.

Brand names:Auvelity
Medication

What people taking Auvelity (Dextromethorphan / Bupropion) report

Every report comes from a Lived member, sent anonymously.

Have you tried Auvelity (Dextromethorphan / Bupropion) for Treatment-Resistant Depression?

NameHow it went

About Auvelity (Dextromethorphan / Bupropion)

What It's For

Auvelity is a prescription medicine that combines two drugs, dextromethorphan and bupropion, in one extended-release tablet. It is approved for two quite different uses: treating major depressive disorder (clinical depression) in adults, and treating agitation in people with dementia caused by Alzheimer's disease. For depression, it is one of several options a clinician may consider, either in place of more familiar antidepressants or after they have not worked well. In its main six-week trial, depressive symptoms improved more than with a placebo, and the difference was already measurable after one and two weeks. Talk therapy remains an option on its own or alongside medication. For agitation in Alzheimer's disease, which can show up as restlessness, verbal outbursts or physical aggression, Auvelity is taken on a regular daily schedule rather than as needed when a difficult episode occurs. It is not approved for children or teenagers, or for treating depression in bipolar disorder.

How It Works

Dextromethorphan is best known as the cough suppressant in many over-the-counter cold medicines. In the brain it also acts on signaling that involves glutamate, the main chemical messenger that excites nerve cells: it blocks a type of glutamate receptor called the NMDA (N-methyl-D-aspartate) receptor and activates another target called the sigma-1 receptor. The body normally clears much of its dextromethorphan through a liver enzyme called CYP2D6. Bupropion, the active ingredient in the antidepressant Wellbutrin XL, blocks that enzyme, which raises and sustains dextromethorphan levels in the blood. Bupropion also has antidepressant effects of its own, probably by acting on the brain chemicals norepinephrine and dopamine. A trial comparing Auvelity with bupropion alone showed that the dextromethorphan adds to the benefit. Exactly how the combination eases depression or agitation is not fully understood.

Dosage & Administration

Auvelity is taken by mouth, with or without food. Because it is an extended-release tablet, it must be swallowed whole, not crushed, split or chewed. For depression, people usually take one tablet each morning for the first three days, then one tablet twice a day, with the two doses at least 8 hours apart. For agitation in Alzheimer's disease, the dose is built up more gradually over about two weeks, starting with a lower-strength tablet, and each step depends on how well it is tolerated. In either case, no more than two doses should be taken in one day. The dose is limited to one tablet a day for people with moderately reduced kidney function, people whose bodies naturally process dextromethorphan slowly, and people taking certain other medicines that block the same liver enzyme. Auvelity is not recommended for people with severe liver disease. Before starting, the prescriber checks blood pressure, asks about any personal or family history of bipolar disorder, and checks whether you already take anything containing bupropion or dextromethorphan.

Side Effects

Dizziness is the most common side effect. In the depression trial, other effects that occurred more often than with placebo included nausea, headache, diarrhea, sleepiness, dry mouth, heavy sweating and sexual side effects such as lower desire or difficulty reaching orgasm. In the Alzheimer's agitation trial, dizziness, sleepiness, indigestion and tiredness stood out. Dizziness raises the risk of falls, which matters most for older adults and anyone with balance or walking problems, and it is sensible to avoid driving until you know how the medicine affects you. Less commonly, Auvelity can cause confusion, hallucinations or paranoid thinking, or set off mania (an abnormally elevated or irritable mood with racing thoughts and little need for sleep) in people prone to bipolar disorder. In the agitation trial, psychotic symptoms such as hallucinations occurred in 3% of people taking Auvelity and in none of those on placebo. These changes should be reported to the prescriber promptly. Bupropion can cause seizures, and the risk rises with dose. Anyone who has a seizure while taking Auvelity needs urgent medical care and should not take it again. Serotonin syndrome, an uncommon but potentially life-threatening reaction that can cause confusion, fever, heavy sweating, shivering, tremor or muscle twitching, also needs emergency care.

Interactions & Warnings

Auvelity carries the boxed warning shared by all antidepressants: in short-term studies, these medicines increased suicidal thoughts and behaviors in children, teenagers and young adults up to age 24. It is not approved for anyone under 18. People of any age, and their families or caregivers, should watch for worsening depression, new suicidal thoughts or unusual changes in behavior, especially in the first months and after a dose change, and contact the prescriber right away if they appear. Because of the seizure risk, Auvelity should not be used by people with a seizure disorder, a current or past eating disorder (bulimia or anorexia), or anyone who is suddenly stopping regular alcohol use or medicines such as benzodiazepines (sedatives such as alprazolam or lorazepam), barbiturates or antiseizure drugs. A serious head injury, stroke, diabetes treated with insulin or tablets, and other medicines that lower the seizure threshold, such as antipsychotics, also add to the risk. Auvelity can raise blood pressure, so blood pressure is checked periodically during treatment. It must never be combined with an MAOI (monoamine oxidase inhibitor, an older type of antidepressant; the antibiotic linezolid and the intravenous dye methylene blue act the same way), and at least 14 days must pass between stopping one and starting the other. Taking it with SSRIs (selective serotonin reuptake inhibitors, the most widely used antidepressant group), tricyclic antidepressants or other drugs that raise serotonin increases the risk of serotonin syndrome. Avoid doubling up on its ingredients: other bupropion products, such as Wellbutrin XL, and over-the-counter cough and cold medicines containing dextromethorphan add to the same doses. Auvelity can also change the levels of other medicines that the CYP2D6 enzyme processes, so a pharmacist should review everything you take. Alcohol should be limited or avoided, and bupropion can cause a false-positive urine drug screen for amphetamines. Auvelity can lower the level of sodium in the blood, especially in older adults and in people taking diuretics (water pills) or another antidepressant that affects serotonin. Its signs, including headache, trouble concentrating, memory problems, new confusion, weakness or unsteadiness, can be mistaken for worsening dementia, so they should be reported to the prescriber, who can check sodium with a blood test. People with untreated narrow drainage angles in the eye can develop angle-closure glaucoma, a sudden rise in eye pressure, so any known narrow angles should be mentioned to the prescriber before starting. Based on animal studies, Auvelity is not recommended during pregnancy, and breastfeeding is not advised during treatment or for 5 days after the last dose. Anyone who becomes pregnant should contact the prescriber promptly to switch treatment, and anyone planning a pregnancy should discuss alternatives first, since untreated depression also carries risks.

What to Expect

For depression, some people notice improvement within the first week or two, but the full effect is judged over about six weeks. Dizziness and other side effects are worth tracking during those early weeks. If depression has not meaningfully improved, or side effects are hard to live with, the prescriber may adjust the plan or suggest a different treatment. For agitation in Alzheimer's disease, caregivers play a central role in judging whether outbursts, restlessness or aggression become less frequent over the first several weeks, and in watching for dizziness, unsteadiness, confusion or new hallucinations. In a longer study, people who had responded and kept taking Auvelity went longer before their agitation returned than those switched to placebo, which supports continuing treatment while it is helping. Follow-up visits usually include blood pressure checks and a review of mood or behavior, side effects and any new medicines, including over-the-counter cough remedies. Decisions about how long to continue and how to stop are made with the prescriber.

Questions to Ask Your Doctor

  1. 1.Why is Auvelity a better fit for me than a standard antidepressant or bupropion on its own?
  2. 2.For agitation in Alzheimer's disease, how will we judge whether it is helping, and which non-drug approaches should we keep using alongside it?
  3. 3.Do any of my current medicines, supplements or cough and cold products interact with Auvelity or change my dose?
  4. 4.Does my health history raise my risk of seizures or high blood pressure, and how will we monitor for them?
  5. 5.If I am planning a pregnancy or breastfeeding, or want to stop treatment later, what would the plan look like?

Last reviewed • Oct 2026

Educational content, not medical advice.